The present study is aimed to modify the structural,
optical, and
morphological properties of CuO thin films with Ag ion implantation
toward their potential applications. Fabrication of thin films of
CuO was carried out using a thermal evaporation technique on silicon
(Si) substrate; post implantation was done with 30 keV Ag ions with
varying fluences from 1 × 1014 to 1 × 1016 ions/cm2. The pristine and implanted samples
were characterized through X-ray diffraction (XRD), Raman spectroscopy,
atomic force microscopy (AFM), and diffused reflectance spectroscopy
(DRS). SRIM simulation was also carried out to understand the range
and other effects. XRD measurements confirmed the formation of the
CuO phase for pristine samples, and with the increase in ion fluence,
the chemical composition changed from pure CuO to Cu2O
+ CuO and then to Cu2O + Cu at higher ion fluences. These
experimental results from Raman spectroscopy were also consistent
with the XRD analysis, which also showed the presence of mixed phases
of CuO, Cu2O, and Cu. Results from AFM showed that the
value of average roughness increased due to more defects. DRS results
revealed the variation in band-gap energy for pristine and implanted
samples from 1.96 to 1.71 eV. Density functional theory (DFT) simulations
confirmed that Ag ion implantation causes the reduction of CuO surface
into Cu2O and Cu. We found that Ag ion implantation-induced
defects lead to the mixed phases of CuO, Cu2O, and Cu,
which can help in the selective sensing of ethanol and acetone, demonstrating
this as a useful technique and having potential applications in energy
conversions, and gas and biomolecule sensing.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.